SCHEMBL10145748

SCHEMBL10145748

Cc1ccc(C(C)C)cc1CNC1CC1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.42
TRPA1 O75762 1/20 0.41
PTGS1 P23219 1/20 0.41
CACNA1C Q13936 1/20 0.41
ACHE P22303 4/20 0.40
BCHE P06276 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ADRB2 P07550 1/20 0.38
CYP2D6 P10635 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
PABPC1 P11940 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36
HTT P42858 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15731765 0.84 ADRB2 (0.38) LMNAACHEBCHEL3MBTL1ADRB2
SCHEMBL879207 0.83 PABPC1 (0.39) ACHEBCHEADRB2CYP2D6PABPC1
SCHEMBL23545671 0.80 TAAR1 (0.44) ACHEADRB2CYP2D6CYP1A2CYP2C9
SCHEMBL14036617 0.78 LMNA (0.48) LMNATRPA1PTGS1CACNA1CACHE
SCHEMBL1072948 0.77 OPRL1 (0.45) ACHEBCHECYP2D6CYP1A2CYP2C9
SCHEMBL10240603 0.75 LMNA (0.46) LMNATRPA1PTGS1CACNA1CACHE
SCHEMBL16980401 0.74 RAB9A (0.53) L3MBTL1MEN1KMT2A
SCHEMBL9668480 0.73 ADRB2 (0.51) ADRB2CYP2D6CYP1A2CYP2C9CYP2C19
SCHEMBL14036776 0.73 PABPC1 (0.44) LMNACYP2D6CYP1A2CYP2C9CYP2C19
SCHEMBL10186648 0.73 MEN1 (0.38) ACHECYP2D6CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120053165-A1 Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators PFIZER INC. (US) 2012-03-01 US disclosed
US-20120053165-A1 Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators PFIZER INC. (US) 2012-03-01 US disclosed
WO-2008137102-A2 METHODS OF MODULATING AMYLOID BETA AND COMPOUNDS USEFUL THEREFOR TORREYPINES THERAPEUTICS, INC. (US) 2008-11-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120053165-A1 Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators BACE1, BACE2, PSEN1 LMNA 2176/4885TRPA1 3804/4885PTGS1 1205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.